Phase Genomics’ ultra-long-range genome sequencing technology and computational tools empower scientists to address some of today’s most pressing health and environmental challenges.
Identify and characterize all major types of chromosomal abnormalities with a single, high-resolution assay to better understand the genetic basis of cancer and inherited diseases.
Read MoreDeconvolute complex metagenomic samples; discover new species, strains and genes; attribute mobile genetic elements to their hosts; study the human microbiome, infectious disease, antibiotic resistance and gene function.
Read MoreConstruct high-quality, chromosome-scale reference genomes; resolve haplotypes and polyploidy; compare and study gene structure, function and interactions; understand biology and evolution to conserve and protect biodiversity.
Read MoreJoin a growing community of scientists who are using proximity genome mapping to enrich genomic data sets and accelerate discovery in life sciences, medicine, and agriculture.
Reach out to discover how Phase Genomics can enhance your research.
Thousands of scientists throughout the world apply Phase Genomics’ technology to drive new innovations and therapeutic discoveries at leading academic and research organizations and biopharmaceutical firms.
“We’ve generated and sequenced more than 70 Phase Genomics libraries so far, leading to numerous highly contiguous plant genomes and chromatin interaction projects. We are incredibly happy with our long-standing relationship with Phase, and look forward to our continued collaborations”
Prof. Alex Harkess
Assistant Professor: Auburn University & Faculty Investigator: HudsonAlpha Institute for Biotechnology“The direct association of mobile genetic elements with their microbial hosts in complex populations is one of the last remaining technological challenges in the microbiome space. Proximity ligation is an elegant way to overcome this obstacle and presents a promising key technology in the study of bacteriophage and antibiotic resistance biology within a microbial context.”
Prof. Paul Plummer
Iowa State University and Executive Director of the Institute for Antimicrobial Resistance Research and Education“The level of genome completeness and contiguity yielded by this technology has transformed how we view genome projects and has enabled us to ask new biological questions.”
Prof. Jeff Maughan
Department of Plant & Wildlife Sciences, Brigham-Young University“The thing that was fun was that [the Phase Genomics team] were definitely personally invested in our research. It wasn’t just a payment for service thing. They were genuinely interested in our results. It’s fun to work with people who are interested in the results.”
Prof. Dr. Catherine (Katie) Peichel
Head: Division Evolutionary Ecology, University of Bern“Metagenomics has drastically accelerated virus discovery, changing our view of virus sequence space from a few hundred viruses to millions. However, the twin grand challenge — to capture full genomes and to link newly discovered viruses to their hosts — are major roadblocks for the field. Promisingly, these early findings suggest that Phase Genomics’ proximity ligation approach may solve both these problems.”
Matthew Sullivan
Professor of Microbiology at Ohio State University and Founding Director of OSU’s Center of Microbiome Science